CheckMan Stock Market Overview

American Rebel Appeals Nasdaq Delisting After Continued Strategic Stockholder Discussions, Ensuring Continued Trading of Common Shares on Nasdaq Under Symbol AREB

Shopify Inc. posted robust Q4 2025 results, with GMV and revenue both up 31% YoY, surpassing consensus estimates. SHOP's full-year 2025 performance showed 30%+ growth across GMV, revenue, and operating income, reinforcing its strong operating momentum. Gross margins continue a gradual structural decline due to the mix shift toward merchant solutions, but operating margins benefit from lower associated expenses.

The Bank of New York Mellon Corporation (BK) Presents at Bank of America Financial Services Conference 2026 Transcript

Ameriprise Financial, Inc. (AMP) Presents at Bank of America Financial Services Conference 2026 Transcript

Allspring Utilities & High Income Fund remains a buy, trading at a 7.08% discount to NAV with an 8.5% yield. ERH's blended equity and high-yield debt strategy generates attractive income but relies heavily on net realized gains for dividend coverage. Leverage (20.9% of assets) amplifies income and risk; potential rate cuts could improve operating spread and future returns.

SiteOne Landscape Supply, Inc. (SITE) Q4 2025 Earnings Call Transcript

Centrus Energy Corp. (LEU) Q4 2025 Earnings Call Transcript

PolyPid Ltd. (PYPD) Q4 2025 Earnings Call Transcript

Ancora is putting pressure on Warner Bros Discovery Inc (NASDAQ:WBD, XETRA:J5A), threatening to vote against the company's proposed transaction with Netflix Inc (NASDAQ:NFLX, XETRA:NFC) and launch a proxy contest if the board does not engage with an enhanced competing bid from Paramount. In a statement, Ancora argued that WBD's board should determine that Paramount's revised proposal, unveiled on Tuesday, “could reasonably be expected to result in a Superior Proposal,” which would allow the company to reopen talks and seek a higher-value outcome for shareholders.

New York, New York--(Newsfile Corp. - February 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Picard Medical, Inc. (NYSE American: PMI) between September 2, 2025 and October 31, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed.